M1 enrichment facilitates virus detection in patients with allogeneic hematopoietic stemcell transplantation
- PMID: 40020100
- PMCID: PMC11875608
- DOI: 10.1097/MD.0000000000041683
M1 enrichment facilitates virus detection in patients with allogeneic hematopoietic stemcell transplantation
Abstract
Due to the severe consequences of viral infection in allogeneic hematopoietic stem cell transplantation (allo-HSCT) patients, the routine use of polymerase chain reaction (PCR) screening of viruses is common in clinic, while the sensitivities of molecular methods are not always sufficient for blood samples. We aimed to increase the detection efficiency of viremia in allo-HSCT patients with M1 bead enrichment. Blood samples of allo-HSCT patients with fever were collected. Simultaneously with analyses of real-time PCR without enrichment, M1 bead enrichment followed by real-time PCR was applied to detect possible viruses in these samples, and metagenomic next-generation sequencing analyses were also applied in 10 samples negative with real-time PCR without enrichment. Various species of viruses were detected with M1 enrichment method. Significantly, some viruses that had not been found by real-time PCR without M1 enrichment were also detected by those with M1 enrichment and verified by metagenomic next-generation sequencing analyses. Furthermore, blood samples enriched with M1 beads had lower Ct values of real-time PCR assay than those that had not been treated. In conclusion, M1 bead enrichment increased the detection efficiency of most viruses in hematological malignancy patients.
Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures

Similar articles
-
Large-scale multiplex polymerase chain reaction assay for diagnosis of viral reactivations after allogeneic hematopoietic stem cell transplantation.J Med Virol. 2015 Aug;87(8):1427-35. doi: 10.1002/jmv.24161. Epub 2015 May 6. J Med Virol. 2015. PMID: 25946433
-
Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies.J Hematol Oncol. 2012 Aug 2;5:46. doi: 10.1186/1756-8722-5-46. J Hematol Oncol. 2012. PMID: 22856463 Free PMC article. Clinical Trial.
-
Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation.Med Microbiol Immunol. 2017 Oct;206(5):355-362. doi: 10.1007/s00430-017-0511-4. Epub 2017 Jul 12. Med Microbiol Immunol. 2017. PMID: 28702856
-
HHV-6 encephalitis may complicate the early phase after allogeneic hematopoietic stem cell transplantation: Detection by qualitative multiplex PCR and subsequent quantitative real-time PCR.J Med Virol. 2016 Feb;88(2):319-23. doi: 10.1002/jmv.24340. Epub 2015 Aug 20. J Med Virol. 2016. PMID: 26241219
-
Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation.J Hematol Oncol. 2013 Dec 17;6:94. doi: 10.1186/1756-8722-6-94. J Hematol Oncol. 2013. PMID: 24341630 Free PMC article. Review.
References
-
- Sahin U, Toprak SK, Atilla PA, Atilla E, Demirer T. An overview of infectious complications after allogeneic haematopoietic stem cell transplantation. J Infect Chemother. 2016;22:505–14. - PubMed
-
- Allaw F, Haddad SF, Zakhour J, Kanj SS. Management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplants. Int J Antimicrob Agents. 2023;62:106860. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical